GE Stock Surges on News of Biopharma Sale
The $21 billion sale to Danaher is a "pivotal milestone" in GE's plan to reduce debt and strengthen its balance sheet, CEO Larry Culp says.
LabCorp Buys U.K. Biopharma Services Firm
The $1.2 billion acquisition of Chiltern continues a wave of consolidation in the contract research organization industry.
Thermo Fisher Moves Into Drug Manufacturing
The $5.2 billion acquisition of Patheon positions Thermo Fisher to grab a slice of the fast-growing contract drug production business.
Puma Biotech Exec Accused of Insider Trading
Robert Gadimian allegedly made $1.1 million by trading on nonpublic information he learned about Puma's breast cancer drug trials.